{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:18:40Z","timestamp":1793812720146,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s13300-019-00729-5","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T19:02:36Z","timestamp":1575313356000},"page":"161-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient\u2019s Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data"],"prefix":"10.1007","volume":"11","author":[{"given":"Diana","family":"\u0160imonien\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aksana","family":"Plat\u016bkiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edita","family":"Prakapien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Radzevi\u010dien\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u017eilda","family":"Veli\u010dkiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,2]]},"reference":[{"issue":"1","key":"729_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s13300-017-0333-9","volume":"9","author":"G Priya","year":"2018","unstructured":"Priya G, Kalra S. A review of insulin resistance in type 1 diabetes: is there a place for adjunctive metformin? Diabetes Ther. 2018;9(1):349\u201361.","journal-title":"Diabetes Ther"},{"issue":"3","key":"729_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2337\/diacare.27.3.775","volume":"27","author":"JS Pankow","year":"2004","unstructured":"Pankow JS, Jacobs DR Jr, Steinberger J, Moran A, Sinaiko AR. Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care. 2004;27(3):775\u201380.","journal-title":"Diabetes Care"},{"issue":"7","key":"729_CR3","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1007\/s00125-013-2904-2","volume":"56","author":"SJ Cleland","year":"2013","unstructured":"Cleland SJ, Fisher BM, Colhoun HM, Sattar N, Petrie JR. Insulin resistance in type 1 diabetes: what is \u2018double diabetes\u2019 and what are the risks? Diabetologia. 2013;56(7):1462\u201370.","journal-title":"Diabetologia"},{"key":"729_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/oxfordjournals.aje.a009572","volume":"148","author":"M Trevisan","year":"1998","unstructured":"Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study: Risk Factor and Life Expectancy Research Group. Am J Epidemiol. 1998;148:958\u201366.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"729_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1464-5491.2010.02956.x","volume":"27","author":"B Conway","year":"2010","unstructured":"Conway B, Miller RG, Costacou T, et al. Temporal patterns in overweight and obesity in type 1 diabetes. Diabet Med. 2010;27(4):398\u2013404.","journal-title":"Diabet Med"},{"issue":"4","key":"729_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/cob.12100","volume":"5","author":"IG Kjaer","year":"2015","unstructured":"Kjaer IG, Kolle E, Hansen BH, Anderssen SA, Torstveit MK. Obesity prevalence in Norwegian adults assessed by body mass index, waist circumference and fat mass percentage. Clin Obes. 2015;5(4):211\u20138.","journal-title":"Clin Obes"},{"key":"729_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2337\/diabetes.47.5.788","volume":"47","author":"M Ishikawa","year":"1998","unstructured":"Ishikawa M, Pruneda ML, Adams-Huet B, Raskin P. Obesity-independent hyperinsulinemia in nondiabetic first-degree relatives of individuals with type 2 diabetes. Diabetes. 1998;47:788\u201392.","journal-title":"Diabetes"},{"issue":"2","key":"729_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.metabol.2013.10.002","volume":"63","author":"JJ Chillar\u00f3n","year":"2014","unstructured":"Chillar\u00f3n JJ, Flores-Le-Roux JA, Benaiges D, Botet JP. Type 1 diabetes, metabolic syndrome and cardiovascular risk. Metabolism. 2014;63(2):181\u20137.","journal-title":"Metabolism"},{"issue":"10","key":"729_CR9","doi-asserted-by":"publisher","first-page":"e1001321","DOI":"10.1371\/journal.pmed.1001321","volume":"9","author":"SJ Livingstone","year":"2012","unstructured":"Livingstone SJ, Looker HC, Hothersall EJ, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish Registry Linkage Study. PLoS Med. 2012;9(10):e1001321.","journal-title":"PLoS Med"},{"issue":"8","key":"729_CR10","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.2337\/dc12-1693","volume":"36","author":"EJ Epstein","year":"2013","unstructured":"Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP. Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care. 2013;36(8):2280\u20135.","journal-title":"Diabetes Care"},{"issue":"9","key":"729_CR11","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1210\/jc.2009-0960","volume":"94","author":"JJ Chillar\u00f3n","year":"2009","unstructured":"Chillar\u00f3n JJ, Goday A, Flores-Le-Roux JA, et al. Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes. J Clin Endocrinol Metab. 2009;94(9):3530\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"729_CR12","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/dom.13110","volume":"20","author":"T Nystr\u00f6m","year":"2018","unstructured":"Nystr\u00f6m T, Holzmann MJ, Eliasson B, Svensson AM, Sartipy U. Estimated glucose disposal rate predicts mortality in adults with type 1 diabetes. Diabetes Obes Metab. 2018;20(3):556\u201363.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"729_CR13","first-page":"I77","volume":"23","author":"ML Bicu","year":"2016","unstructured":"Bicu ML, Bicu D, Gargavu S, Sandu M. Estimated glucose disposal rate (eGDR)\u2014a marker for the assessment of insulin resistance in type 1 diabetes mellitus. Rom J Diabetes Nutr Metab Dis. 2016;23(2):I77\u2013182.","journal-title":"Rom J Diabetes Nutr Metab Dis"},{"issue":"1","key":"729_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1530\/EC-12-0057","volume":"2","author":"B Daka","year":"2012","unstructured":"Daka B, Rosen T, Jansson PA, R\u00e5stam L, Larsson CA, Lindblad U. Inverse association between serum insulin and sex hormone-binding globulin in a population survey in Sweden. Endocr Connect. 2012;2(1):18\u201322.","journal-title":"Endocr Connect"},{"issue":"2","key":"729_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/ilar.45.2.160","volume":"45","author":"CM Bruns","year":"2004","unstructured":"Bruns CM, Kemnitz JW. Sex hormones, insulin sensitivity, and diabetes mellitus. ILAR J. 2004;45(2):160\u20139.","journal-title":"ILAR J"},{"key":"729_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cen.12086","volume":"78","author":"IR Wallace","year":"2013","unstructured":"Wallace IR, McKinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance. J Clin Endocrinol. 2013;78:321\u20139.","journal-title":"J Clin Endocrinol"},{"issue":"5","key":"729_CR17","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","volume":"27","author":"DE Laaksonen","year":"2004","unstructured":"Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004;27(5):1036\u201341.","journal-title":"Diabetes Care"},{"key":"729_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/s-2005-865807","volume":"113","author":"AH Heald","year":"2005","unstructured":"Heald AH, Anderson SG, Ivison F, et al. Low sex hormone binding globulin is a potential marker for the metabolic syndrome in different ethnic groups. Exp Clin Endocrinol Diabetes. 2005;113:522\u20138.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"729_CR19","first-page":"547","volume":"44","author":"L Christensen","year":"1997","unstructured":"Christensen L, Hagen C, Henriksen JE, Haug E. Elevated levels of sex hormones and sex hormone binding globulin in male patients with insulin dependent diabetes mellitus. Effect of improved blood glucose regulation. Dan Med Bull. 1997;44(5):547\u201350.","journal-title":"Dan Med Bull"},{"issue":"Suppl.","key":"729_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/sj.ijo.0801279","volume":"24","author":"SM Haffner","year":"2000","unstructured":"Haffner SM. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation. Int J Obes Relat Metab Disord. 2000;24(Suppl.):56\u20138.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"1","key":"729_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2337\/diacare.25.1.55","volume":"25","author":"JY Oh","year":"2002","unstructured":"Oh JY, Barrett-Connor E, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care. 2002;25(1):55\u201360.","journal-title":"Diabetes Care"},{"issue":"3","key":"729_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4103\/2230-8229.122006","volume":"20","author":"AA Al Hayek","year":"2013","unstructured":"Al Hayek AA, Khader YS, Jafal S, Khawaja N, Robert AA, Ajlouni K. Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study. J Family Community Med. 2013;20(3):179\u201386.","journal-title":"J Family Community Med"},{"issue":"5","key":"729_CR23","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1210\/jc.2007-2177","volume":"93","author":"M Grossmann","year":"2008","unstructured":"Grossmann M, Thomas MC, Panagiotopoulos S, et al. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008;93(5):1834\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"729_CR24","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.2337\/diacare.26.6.1812","volume":"26","author":"EWCM van Dam","year":"2003","unstructured":"van Dam EWCM, Dekker JM, Lentjes EGWM, et al. Steroids in adult men with type 1 diabetes: a tendency to hypogonadism. Diabetes Care. 2003;26(6):1812\u20138.","journal-title":"Diabetes Care"},{"issue":"8","key":"729_CR25","first-page":"552","volume":"3","author":"A Rezaianzadeh","year":"2012","unstructured":"Rezaianzadeh A, Namayandeh SM, Sadr SM. National Cholesterol Education Program Adult Treatment Panel III versus International Diabetic Federation definition of metabolic syndrome, which one is associated with diabetes mellitus and coronary artery disease? Int J Prev Med. 2012;3(8):552\u20138.","journal-title":"Int J Prev Med"},{"key":"729_CR26","doi-asserted-by":"crossref","unstructured":"Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Arch Intern Med. 1998;158(17):1855\u201367.","DOI":"10.1001\/archinte.158.17.1855"},{"issue":"4","key":"729_CR27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","volume":"49","author":"K Williams","year":"2000","unstructured":"Williams K, Erbey J, Becker D, Arslanian S. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49(4):626\u201332.","journal-title":"Diabetes"},{"issue":"2","key":"729_CR28","first-page":"459","volume":"36","author":"T Bulum","year":"2012","unstructured":"Bulum T, Duvnjak L, Prkacin I. Estimated glucose disposal rate in assessment of renal function in patients with type 1 diabetes. Coll Antropol. 2012;36(2):459\u201365.","journal-title":"Coll Antropol"},{"issue":"4","key":"729_CR29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556\u201363.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"729_CR30","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2337\/dc11-2339","volume":"35","author":"CS Tam","year":"2012","unstructured":"Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E. Defining insulin resistance from hyperinsulinemic\u2013euglycemic clamps. Diabetes Care. 2012;35(7):1605\u201310.","journal-title":"Diabetes Care"},{"issue":"6","key":"729_CR31","first-page":"253","volume":"2","author":"M Vladu","year":"2017","unstructured":"Vladu M, Clenciu D, Efrem IC, et al. Insulin resistance and chronic kidney disease in patients with type 1 diabetes mellitus. J Nutr Metab. 2017;2(6):253\u20139.","journal-title":"J Nutr Metab"},{"issue":"2","key":"729_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/1753-0407.12283","volume":"8","author":"A Pop","year":"2016","unstructured":"Pop A, Clenciu D, Anghel M, et al. Insulin resistance is associated with all chronic complications in type 1 diabetes. J Diabetes. 2016;8(2):220\u20138.","journal-title":"J Diabetes"},{"key":"729_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1047-2797(01)00269-1","volume":"12","author":"JC Olson","year":"2002","unstructured":"Olson JC, Erbey JR, Williams KV, et al. Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes. Ann Epidemiol. 2002;12:331\u20137.","journal-title":"Ann Epidemiol"},{"issue":"2","key":"729_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2337\/diacare.24.2.284","volume":"24","author":"N Chaturvedi","year":"2001","unstructured":"Chaturvedi N, Sjoelie AK, Porta M, et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. The EURODIAB Prospective Complication. Diabetes Care. 2001;24(2):284\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"729_CR35","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2337\/dc06-1982","volume":"30","author":"ES Kilpatrick","year":"2007","unstructured":"Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: \u201cDouble diabetes\u201d in the Diabetes Control and Complications Trial. Diabetes Care. 2007;30(3):707\u201312.","journal-title":"Diabetes Care"},{"key":"729_CR36","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998;41:416\u201323.","DOI":"10.1007\/s001250050924"},{"issue":"2","key":"729_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/jama.280.2.140","volume":"280","author":"JQ Purnell","year":"1998","unstructured":"Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA. 1998;280(2):140\u20136.","journal-title":"JAMA"},{"issue":"1","key":"729_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193\u2013203.","journal-title":"Diabetes Care"},{"issue":"Sup 2","key":"729_CR39","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.2337\/dcS15-3014","volume":"39","author":"M Hanefeld","year":"2016","unstructured":"Hanefeld M, Frier BM, Pistrosch F. Hypoglycemia and cardiovascular risk: is there a major link? Diabetes Care. 2016;39(Sup 2):S205\u20139.","journal-title":"Diabetes Care"},{"key":"729_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1758-5996-6-131","volume":"6","author":"MM Teixeira","year":"2014","unstructured":"Teixeira MM, Diniz Mde F, Reis JS, et al. Insulin resistance and associated factors in patients with type 1 diabetes. Diabetol Metab Syndr. 2014;6:131.","journal-title":"Diabetol Metab Syndr"},{"issue":"3","key":"729_CR41","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2337\/dc09-1220","volume":"33","author":"KK Danielson","year":"2009","unstructured":"Danielson KK, Drum ML, Estrada CL, Lipton RB. Racial and ethnic differences in an estimated measure of insulin resistance among individuals with type 1 diabetes. Diabetes Care. 2009;33(3):614\u20139.","journal-title":"Diabetes Care"},{"issue":"Sup 1","key":"729_CR42","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.genm.2009.02.002","volume":"6","author":"EB Geer","year":"2009","unstructured":"Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6(Sup 1):60\u201375.","journal-title":"Gend Med"},{"issue":"2","key":"729_CR43","doi-asserted-by":"publisher","first-page":"122","DOI":"10.5603\/DK.2018.0007","volume":"7","author":"A Uruska","year":"2018","unstructured":"Uruska A, Araszkiewicz A, Uruski P, Naskret D, Zozulinska-Ziolkiewicz D. Smokers with type 1 diabetes are more insulin-resistant. Results from Poznan Prospective Study (PoProStu). Clin Diabetol. 2018;7(2):122\u20137.","journal-title":"Clin Diabetol"},{"issue":"12","key":"729_CR44","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.2337\/db12-0418","volume":"61","author":"BC Bergman","year":"2012","unstructured":"Bergman BC, Perreault L, Hunerdosse D, et al. Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes. 2012;61(12):3156\u201366.","journal-title":"Diabetes"},{"key":"729_CR45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2337\/diacare.17.5.405","volume":"17","author":"B Andersson","year":"1994","unstructured":"Andersson B, Marin P, Lissner L, Vermeulen A, Bjorntorp P. Testosterone concentrations in women and men with NIDDM. Diabetes Care. 1994;17:405\u201311.","journal-title":"Diabetes Care"},{"key":"729_CR46","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1210\/jc.2004-0804","volume":"89","author":"S Dhindsa","year":"2004","unstructured":"Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004;89:5462\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"729_CR47","first-page":"275","volume":"76","author":"KI Birkeland","year":"1993","unstructured":"Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab. 1993;76:275\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"729_CR48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2337\/diab.43.2.212","volume":"43","author":"SM Haffner","year":"1994","unstructured":"Haffner SM, Karhapaa P, Mykkanen L, Laakso M. Insulin resistance, body fat distribution, and sex hormones in men. Diabetes. 1994;43:212\u20139.","journal-title":"Diabetes"},{"key":"729_CR49","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1210\/jc.2002-020567","volume":"87","author":"N Abate","year":"2002","unstructured":"Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM. Sex steroid hormones, upper body obesity, and insulin resistance. Clin Endocrinol Metab. 2002;87:4522\u20137.","journal-title":"Clin Endocrinol Metab"},{"issue":"5","key":"729_CR50","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","volume":"86","author":"C Weyer","year":"2001","unstructured":"Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"729_CR51","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.2337\/diabetes.52.10.2623","volume":"52","author":"JQ Purnell","year":"2003","unstructured":"Purnell JQ, Dev RK, Steffes MW, et al. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial. Diabetes. 2003;52(10):2623\u20139.","journal-title":"Diabetes"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-019-00729-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-019-00729-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-019-00729-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T11:09:03Z","timestamp":1724411343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-019-00729-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1007\/s13300-019-00729-5","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,2]]},"assertion":[{"value":"2 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}